Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Guelph

$24,987.00

Enhancing antibody efficacy in plants via targeted manipulation of dolichol biosynthesis

FY 2015-16

Summary
PlantForm Corporation is a Canadian company that specializes in turning plants into versatile 'bioreactors' for the production of therapeutic proteins used in the treatment of HIV/AIDS, breast and other forms of cancer. Compared to current animal systems that are used to produce protein based therapeutics, PlantForm's plant-based production system lowers the manufacturing costs considerably. Any advancement in PlantForm's mAbs production efficiency will not only give them a competitive edge in this billion dollar biopharmaceutical market, but lower production costs translate into lower treatment costs for the thousands of Canadians who are affected by such diseases. The objective of this research project is to enhance PlantForm's bioproduction platform by incorporating technology that has recently been developed by Dr. Tariq Akhtar at the University of Guelph. Specifically, this research project aims to improve the yield of functional monoclonal antibodies that can be produced in plants.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
481364-2015
Name nom
Akhtar, Tariq
Department département
Molecular and Cellular Biology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
24987
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
103
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Plant production and plant primary products
Area of application fr
Production végétale et produits végétaux primaires
Research subject code
4900
Research subject group en
Plant and treebiology
Research subject group fr
Biologie végétale et des arbres
Research subject en
Plant and treebiology
Research subject fr
Biologie végétale et des arbres
Partie
1
Nb partie
1
Application title
Enhancing antibody efficacy in plants via targeted manipulation of dolichol biosynthesis
Keyword
NSERC
Application summary
PlantForm Corporation is a Canadian company that specializes in turning plants into versatile 'bioreactors' for the production of therapeutic proteins used in the treatment of HIV/AIDS, breast and other forms of cancer. Compared to current animal systems that are used to produce protein based therapeutics, PlantForm's plant-based production system lowers the manufacturing costs considerably. Any advancement in PlantForm's mAbs production efficiency will not only give them a competitive edge in this billion dollar biopharmaceutical market, but lower production costs translate into lower treatment costs for the thousands of Canadians who are affected by such diseases. The objective of this research project is to enhance PlantForm's bioproduction platform by incorporating technology that has recently been developed by Dr. Tariq Akhtar at the University of Guelph. Specifically, this research project aims to improve the yield of functional monoclonal antibodies that can be produced in plants.